Tri-Med Associates: The DOJ Found This Hospice Company Enrolled Patients Who Were Not Terminally Ill to Bill Medicare for Care They Didn't Qualify For

Tri-Med Associates Inc. and its principals faced Department of Justice charges under the False Claims Act after investigators found the hospice company had enrolled patients in its Medicare hospice program who did not meet the eligibility requirement that patients have a terminal prognosis of six months or less to live if the disease runs its natural course — billing Medicare for hospice care for patients who were not terminally ill and, in some cases, for patients who received limited actual hospice services despite generating significant Medicare billing under Tri-Med's accounts.DOCUMENTED

Hospice fraud has been a sustained focus of DOJ and HHS enforcement because the Medicare hospice benefit is particularly susceptible to abuse: reimbursement is structured as a per-diem payment for each day a patient is enrolled in hospice, creating a financial incentive to maintain large census populations and to keep patients enrolled regardless of whether their condition remains consistent with the terminal prognosis requirement. Companies that enroll ineligible patients and maintain them on hospice rolls collect the daily payment without delivering the genuine hospice services — specialized palliative care, symptom management, emotional support, and caregiver assistance — that the benefit is designed to fund.

Medicare Hospice Eligibility Requirements

The Medicare hospice benefit provides comprehensive palliative care — focused on comfort and quality of life rather than curative treatment — to Medicare beneficiaries who have a terminal illness with a life expectancy of six months or less if the disease runs its natural course. To enroll in Medicare hospice, a patient must have a physician certify that the terminal prognosis requirement is met and must elect to receive hospice care in lieu of curative treatment for the terminal condition. Once enrolled, the patient receives a package of services — nursing visits, aide assistance, medical social work, chaplaincy, and medications and equipment related to the terminal diagnosis — paid for by Medicare on a per-diem basis regardless of the actual services delivered on any given day.REVIEWED

The per-diem payment structure creates the central economic dynamic in hospice fraud: a hospice provider receives payment for every day a patient is enrolled, regardless of whether the patient received services on that day and regardless of whether the patient's condition continues to warrant hospice enrollment. A provider that maintains a large census of enrolled patients — even patients who are not truly terminal or who receive minimal services — collects the daily payments for each of those patients every day, generating revenue that does not correspond to genuine hospice services delivered to appropriately enrolled patients. The fraud investigation typically focuses on two related questions: whether enrolled patients met the terminal prognosis requirement at the time of enrollment and at each recertification, and whether the patients received the services for which Medicare was billed.DOCUMENTED

The Physician Certification Problem

Medicare hospice eligibility requires physician certification of the terminal prognosis — a certification that must be renewed periodically for patients who remain on hospice. Hospice fraud schemes that enroll ineligible patients must obtain physician certifications for those patients, which they do through several mechanisms: physicians who are compensated in ways linked to hospice census enrollment may certify patients whose condition does not genuinely meet the terminal prognosis standard, hospice companies may provide physicians with documentation that misrepresents the patient's clinical status to support a certification the physician might not provide with accurate information, or the certification may be provided by a physician who has a nominal review of the patient's chart without the clinical assessment needed to genuinely evaluate the terminal prognosis claim.REVIEWED

The DOJ's investigation of Tri-Med Associates examined the clinical records supporting the physician certifications for enrolled patients, comparing the documented clinical status with the terminal prognosis certification and with the outcomes for patients whose condition improved or stabilized after enrollment — a pattern inconsistent with genuine terminal illness. Patients who survive for extended periods after hospice enrollment are not necessarily fraudulently enrolled, since prognosis is inherently uncertain; but patterns of very long hospice stays combined with clinical documentation inconsistent with terminal prognosis support inferences about whether the enrollment decisions were clinically grounded or primarily financially motivated.DOCUMENTED

Enrolling a patient in hospice who is not dying is not aggressive hospice marketing. It is billing Medicare for end-of-life care for someone who does not need it — while taking them off curative treatment they might benefit from, and calling it compassion.

Services Not Provided

The DOJ's complaint against Tri-Med also documented the inadequacy of services actually provided to enrolled patients relative to the per-diem payments Medicare made on their behalf. Patients who are appropriately enrolled in hospice are entitled under the Medicare benefit to a defined package of services — skilled nursing visits, home health aide assistance, social work, chaplaincy, and related services — at intervals determined by the patient's care plan. When a hospice provider bills Medicare the per-diem rate but does not deliver the required services — sending nursing visits less frequently than required, not providing aide services, or failing to ensure that patients have access to the full range of benefit services — it is collecting payment for services not delivered, a false claim independent of the enrollment eligibility question.DOCUMENTED

The combination of ineligible enrollment and inadequate service delivery makes cases like Tri-Med Among the more egregious examples of hospice fraud: not only are Medicare funds spent on patients who should not be in hospice, but those patients are receiving inadequate services for whatever care needs they have. The financial harm to Medicare is compounded by the patient care harm — patients who are not terminal are not receiving curative treatment they could benefit from, and patients who are legitimately enrolled are not receiving the full range of services they are entitled to under the benefit. The DOJ's enforcement serves both the financial integrity of the Medicare program and the patient care interests that the hospice benefit is designed to serve.

The Hospice Industry's Compliance Obligations

Legitimate hospice providers operating in good faith face challenges that fraud operators exploit: prognosis is inherently uncertain, some genuinely terminal patients survive longer than expected, and the clinical judgment involved in certifying terminal status involves genuine uncertainty. The compliance framework for hospice providers must navigate this uncertainty by implementing robust clinical assessment processes — genuine physician evaluation of each patient's condition at certification and recertification, interdisciplinary team review that involves nursing, social work, and other clinical perspectives, and documentation practices that clearly support the clinical basis for the terminal prognosis certification. Hospice compliance programs that maintain clinical rigor in enrollment and recertification decisions, and that monitor claims for patterns of long stays or minimal service delivery, can identify and address potential compliance issues before they become enforcement targets — and can demonstrate good faith clinical judgment when enrollment decisions are scrutinized by investigators.

Have documents relevant to this story? Reach us through our tips channel.